Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-003424
Filing Date
2023-02-13
Accepted
2023-02-13 21:01:27
Documents
1
Period of Report
2023-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167634007134725.html 4  
1 FORM 4 wf-form4_167634007134725.xml 4 3996
  Complete submission text file 0001628280-23-003424.txt   5417
Mailing Address C/O MIRAGEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD, #100 BOULDER CO 80301
Business Address
Levy Adam Scott (Reporting) CIK: 0001693134 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 23621466

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations